Global Therapeutic Radioligands Market Research Report 2024(Status and Outlook)

Global Therapeutic Radioligands Market Research Report 2024(Status and Outlook)



Report Overview:

Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.

The Global Therapeutic Radioligands Market Size was estimated at USD 1711.57 million in 2023 and is projected to reach USD 4481.29 million by 2029, exhibiting a CAGR of 17.40% during the forecast period.

This report provides a deep insight into the global Therapeutic Radioligands market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Radioligands Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Radioligands market in any manner.

Global Therapeutic Radioligands Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer

Novartis

Lantheus

Aurobindo Pharma

Mundipharma

China Isotope & Radiation

Curium Pharmaceuticals

Gilead Sciences

Clarity Pharmaceuticals

Curasight

Nordic Nanovector

Philogen

RadioMedix

Telix Pharmaceuticals

Orano Med

Actinium Pharmaceuticals

Y-mAbs Therapeutics

Fusion Pharmaceuticals

Market Segmentation (by Type)

Beta-emitting

Targeted Alpha Therapy

Market Segmentation (by Application)

Solid Tumor

Non Hodgkin Lymphoma

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Therapeutic Radioligands Market

Overview of the regional outlook of the Therapeutic Radioligands Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Radioligands Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Therapeutic Radioligands
1.2 Key Market Segments
1.2.1 Therapeutic Radioligands Segment by Type
1.2.2 Therapeutic Radioligands Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Therapeutic Radioligands Market Overview
2.1 Global Market Overview
2.1.1 Global Therapeutic Radioligands Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Therapeutic Radioligands Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Therapeutic Radioligands Market Competitive Landscape
3.1 Global Therapeutic Radioligands Sales by Manufacturers (2019-2024)
3.2 Global Therapeutic Radioligands Revenue Market Share by Manufacturers (2019-2024)
3.3 Therapeutic Radioligands Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Radioligands Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Therapeutic Radioligands Sales Sites, Area Served, Product Type
3.6 Therapeutic Radioligands Market Competitive Situation and Trends
3.6.1 Therapeutic Radioligands Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Radioligands Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Therapeutic Radioligands Industry Chain Analysis
4.1 Therapeutic Radioligands Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Therapeutic Radioligands Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Therapeutic Radioligands Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Radioligands Sales Market Share by Type (2019-2024)
6.3 Global Therapeutic Radioligands Market Size Market Share by Type (2019-2024)
6.4 Global Therapeutic Radioligands Price by Type (2019-2024)
7 Therapeutic Radioligands Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Radioligands Market Sales by Application (2019-2024)
7.3 Global Therapeutic Radioligands Market Size (M USD) by Application (2019-2024)
7.4 Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
8 Therapeutic Radioligands Market Segmentation by Region
8.1 Global Therapeutic Radioligands Sales by Region
8.1.1 Global Therapeutic Radioligands Sales by Region
8.1.2 Global Therapeutic Radioligands Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Radioligands Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Radioligands Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Radioligands Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Radioligands Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Radioligands Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bayer
9.1.1 Bayer Therapeutic Radioligands Basic Information
9.1.2 Bayer Therapeutic Radioligands Product Overview
9.1.3 Bayer Therapeutic Radioligands Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Therapeutic Radioligands SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Therapeutic Radioligands Basic Information
9.2.2 Novartis Therapeutic Radioligands Product Overview
9.2.3 Novartis Therapeutic Radioligands Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Therapeutic Radioligands SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Lantheus
9.3.1 Lantheus Therapeutic Radioligands Basic Information
9.3.2 Lantheus Therapeutic Radioligands Product Overview
9.3.3 Lantheus Therapeutic Radioligands Product Market Performance
9.3.4 Lantheus Therapeutic Radioligands SWOT Analysis
9.3.5 Lantheus Business Overview
9.3.6 Lantheus Recent Developments
9.4 Aurobindo Pharma
9.4.1 Aurobindo Pharma Therapeutic Radioligands Basic Information
9.4.2 Aurobindo Pharma Therapeutic Radioligands Product Overview
9.4.3 Aurobindo Pharma Therapeutic Radioligands Product Market Performance
9.4.4 Aurobindo Pharma Business Overview
9.4.5 Aurobindo Pharma Recent Developments
9.5 Mundipharma
9.5.1 Mundipharma Therapeutic Radioligands Basic Information
9.5.2 Mundipharma Therapeutic Radioligands Product Overview
9.5.3 Mundipharma Therapeutic Radioligands Product Market Performance
9.5.4 Mundipharma Business Overview
9.5.5 Mundipharma Recent Developments
9.6 China Isotope and Radiation
9.6.1 China Isotope and Radiation Therapeutic Radioligands Basic Information
9.6.2 China Isotope and Radiation Therapeutic Radioligands Product Overview
9.6.3 China Isotope and Radiation Therapeutic Radioligands Product Market Performance
9.6.4 China Isotope and Radiation Business Overview
9.6.5 China Isotope and Radiation Recent Developments
9.7 Curium Pharmaceuticals
9.7.1 Curium Pharmaceuticals Therapeutic Radioligands Basic Information
9.7.2 Curium Pharmaceuticals Therapeutic Radioligands Product Overview
9.7.3 Curium Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.7.4 Curium Pharmaceuticals Business Overview
9.7.5 Curium Pharmaceuticals Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Therapeutic Radioligands Basic Information
9.8.2 Gilead Sciences Therapeutic Radioligands Product Overview
9.8.3 Gilead Sciences Therapeutic Radioligands Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Clarity Pharmaceuticals
9.9.1 Clarity Pharmaceuticals Therapeutic Radioligands Basic Information
9.9.2 Clarity Pharmaceuticals Therapeutic Radioligands Product Overview
9.9.3 Clarity Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.9.4 Clarity Pharmaceuticals Business Overview
9.9.5 Clarity Pharmaceuticals Recent Developments
9.10 Curasight
9.10.1 Curasight Therapeutic Radioligands Basic Information
9.10.2 Curasight Therapeutic Radioligands Product Overview
9.10.3 Curasight Therapeutic Radioligands Product Market Performance
9.10.4 Curasight Business Overview
9.10.5 Curasight Recent Developments
9.11 Nordic Nanovector
9.11.1 Nordic Nanovector Therapeutic Radioligands Basic Information
9.11.2 Nordic Nanovector Therapeutic Radioligands Product Overview
9.11.3 Nordic Nanovector Therapeutic Radioligands Product Market Performance
9.11.4 Nordic Nanovector Business Overview
9.11.5 Nordic Nanovector Recent Developments
9.12 Philogen
9.12.1 Philogen Therapeutic Radioligands Basic Information
9.12.2 Philogen Therapeutic Radioligands Product Overview
9.12.3 Philogen Therapeutic Radioligands Product Market Performance
9.12.4 Philogen Business Overview
9.12.5 Philogen Recent Developments
9.13 RadioMedix
9.13.1 RadioMedix Therapeutic Radioligands Basic Information
9.13.2 RadioMedix Therapeutic Radioligands Product Overview
9.13.3 RadioMedix Therapeutic Radioligands Product Market Performance
9.13.4 RadioMedix Business Overview
9.13.5 RadioMedix Recent Developments
9.14 Telix Pharmaceuticals
9.14.1 Telix Pharmaceuticals Therapeutic Radioligands Basic Information
9.14.2 Telix Pharmaceuticals Therapeutic Radioligands Product Overview
9.14.3 Telix Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.14.4 Telix Pharmaceuticals Business Overview
9.14.5 Telix Pharmaceuticals Recent Developments
9.15 Orano Med
9.15.1 Orano Med Therapeutic Radioligands Basic Information
9.15.2 Orano Med Therapeutic Radioligands Product Overview
9.15.3 Orano Med Therapeutic Radioligands Product Market Performance
9.15.4 Orano Med Business Overview
9.15.5 Orano Med Recent Developments
9.16 Actinium Pharmaceuticals
9.16.1 Actinium Pharmaceuticals Therapeutic Radioligands Basic Information
9.16.2 Actinium Pharmaceuticals Therapeutic Radioligands Product Overview
9.16.3 Actinium Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.16.4 Actinium Pharmaceuticals Business Overview
9.16.5 Actinium Pharmaceuticals Recent Developments
9.17 Y-mAbs Therapeutics
9.17.1 Y-mAbs Therapeutics Therapeutic Radioligands Basic Information
9.17.2 Y-mAbs Therapeutics Therapeutic Radioligands Product Overview
9.17.3 Y-mAbs Therapeutics Therapeutic Radioligands Product Market Performance
9.17.4 Y-mAbs Therapeutics Business Overview
9.17.5 Y-mAbs Therapeutics Recent Developments
9.18 Fusion Pharmaceuticals
9.18.1 Fusion Pharmaceuticals Therapeutic Radioligands Basic Information
9.18.2 Fusion Pharmaceuticals Therapeutic Radioligands Product Overview
9.18.3 Fusion Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.18.4 Fusion Pharmaceuticals Business Overview
9.18.5 Fusion Pharmaceuticals Recent Developments
10 Therapeutic Radioligands Market Forecast by Region
10.1 Global Therapeutic Radioligands Market Size Forecast
10.2 Global Therapeutic Radioligands Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Radioligands Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Radioligands Market Size Forecast by Region
10.2.4 South America Therapeutic Radioligands Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Radioligands by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Therapeutic Radioligands Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Therapeutic Radioligands by Type (2025-2030)
11.1.2 Global Therapeutic Radioligands Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Therapeutic Radioligands by Type (2025-2030)
11.2 Global Therapeutic Radioligands Market Forecast by Application (2025-2030)
11.2.1 Global Therapeutic Radioligands Sales (Kilotons) Forecast by Application
11.2.2 Global Therapeutic Radioligands Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings